Jamison Private Wealth Management Inc. Purchases 648 Shares of Cardinal Health, Inc. (NYSE:CAH)

Jamison Private Wealth Management Inc. raised its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 2.7% during the fourth quarter, Holdings Channel reports. The fund owned 24,461 shares of the company’s stock after buying an additional 648 shares during the period. Jamison Private Wealth Management Inc.’s holdings in Cardinal Health were worth $2,893,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in CAH. Paragon Capital Management Inc. grew its holdings in Cardinal Health by 0.7% during the 2nd quarter. Paragon Capital Management Inc. now owns 14,758 shares of the company’s stock worth $1,451,000 after acquiring an additional 99 shares in the last quarter. Huntington National Bank lifted its position in shares of Cardinal Health by 0.9% in the 3rd quarter. Huntington National Bank now owns 10,792 shares of the company’s stock worth $1,193,000 after purchasing an additional 100 shares during the period. Frazier Financial Advisors LLC boosted its stake in shares of Cardinal Health by 69.8% during the third quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock valued at $28,000 after purchasing an additional 104 shares in the last quarter. UMB Bank n.a. increased its holdings in Cardinal Health by 4.9% during the third quarter. UMB Bank n.a. now owns 2,249 shares of the company’s stock valued at $249,000 after buying an additional 106 shares during the period. Finally, Raleigh Capital Management Inc. raised its stake in Cardinal Health by 29.6% in the fourth quarter. Raleigh Capital Management Inc. now owns 464 shares of the company’s stock valued at $55,000 after buying an additional 106 shares during the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Stock Down 0.3 %

CAH stock opened at $128.89 on Friday. The stock has a market capitalization of $31.19 billion, a P/E ratio of 25.08, a P/E/G ratio of 1.57 and a beta of 0.63. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $129.68. The firm has a 50-day simple moving average of $121.36 and a 200-day simple moving average of $113.04.

Cardinal Health (NYSE:CAH) last announced its earnings results on Friday, November 1st. The company reported $1.88 EPS for the quarter, beating analysts’ consensus estimates of $1.62 by $0.26. The business had revenue of $52.28 billion during the quarter, compared to analysts’ expectations of $50.90 billion. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The business’s revenue was down 4.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.73 earnings per share. On average, analysts expect that Cardinal Health, Inc. will post 7.82 earnings per share for the current year.

Cardinal Health Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd were paid a dividend of $0.5056 per share. The ex-dividend date was Thursday, January 2nd. This represents a $2.02 annualized dividend and a yield of 1.57%. Cardinal Health’s dividend payout ratio (DPR) is presently 39.30%.

Wall Street Analyst Weigh In

A number of research firms have issued reports on CAH. Citigroup raised their price target on shares of Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a report on Friday, January 10th. StockNews.com lowered Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd. Barclays raised their price target on shares of Cardinal Health from $117.00 to $133.00 and gave the stock an “overweight” rating in a research report on Monday, November 4th. Morgan Stanley boosted their target price on shares of Cardinal Health from $127.00 to $136.00 and gave the company an “overweight” rating in a research report on Tuesday, December 17th. Finally, JPMorgan Chase & Co. lifted their price target on Cardinal Health from $132.00 to $142.00 and gave the company a “neutral” rating in a research report on Friday. Four research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $134.64.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.